Clinical analysis of imatinib mesylate as the first-line treatment for patients with recurrent or metastatic gastrointestinal stromal tumors

LIU Xiufeng; QIN Shukui; WANG Lin; CHEN Yingxia; HUA Haiqing; GONG Xinlei; CAO Mengran; FANG Rong

doi:10.3969/j.issn.1009-0460.2013.01.010

Home>Articles>Clinical analysis of imatinib mesylate as the first-line treatment for patients with recurrent or metastatic gastrointestinal stromal tumors

DOI: 10.3969/j.issn.1009-0460.2013.01.010

Clinical analysis of imatinib mesylate as the first-line treatment for patients with recurrent or metastatic gastrointestinal stromal tumors

LIU Xiufeng

QIN Shukui

WANG Lin

CHEN Yingxia

HUA Haiqing

GONG Xinlei

CAO Mengran

FANG Rong

Machine-generated Keywords：

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 45-49 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(1)